[Proliferative kinetics of human genital carcinoma following the action of cytostatics and hormones in in vivo tests].
D000230:Adenocarcinoma / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004717:Endometrium / Q000473:pathology; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000473:pathology; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D066298:In Vitro Techniques; D008727:Methotrexate / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011372:Progestins / Q000627:therapeutic use; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000473:pathology; D014594:Uterine Neoplasms / Q000188:drug therapy; D014625:Vaginal Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000627:therapeutic use; D014846:Vulvar Neoplasms / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D000970:Antineoplastic Agents; D004967:Estrogens; D012739:Gonadal Steroid Hormones; D011372:Progestins; D014747:Vinblastine; D008727:Methotrexate
Die Proliferationskinetik menschlicher Genitalkarziome nach Einwirkung von Zytostatika und Hormonen im in-vivo-Test.